E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 3/15/2012 in the Prospect News Bank Loan Daily.

DJO Finance extends $390 million of term loan borrowings to 2016

By Sara Rosenberg

New York, March 15 - DJO Finance LLC extended roughly $389.6 million of its term loan to November 2016 from May 2014, leaving about $103.5 million of non-extended term loan debt following planned pay downs, according to a market source.

Pricing on the extended loan is Libor plus 500 basis points, versus non-extended pricing of Libor plus 300 bps.

With the amendment and extension, the company is getting a $350 million incremental term loan (Ba2/BB-) due September 2017 that is priced at Libor plus 500 bps with a 1.25% Libor floor and an original issue discount of 981/2.

The incremental term loan had been upsized from $300 million during syndication.

Proceeds from the incremental loan are being used to repay some outstanding term loan debt, which, prior to the extension and the paydown, totaled around $843 million.

DJO is also getting a new $100 million five-year revolver (Ba2/BB-) to replace its existing revolver.

Credit Suisse Securities (USA) LLC, Goldman Sachs & Co., Macquarie Capital, RBC Capital Markets LLC, UBS Securities LLC and Wells Fargo Securities LLC are the lead banks on the deal.

DJO Finance is a Vista, Calif.-based developer, manufacturer and distributor of medical devices for musculoskeletal health, vascular health and pain management.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.